Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction

INTRODUCTION: Heart failure is a frequent complication after acute myocardial infarction (MI) and carries a poor prognosis. Current treatments inhibit the renin-angiotensin-aldosterone system but suppression of aldosterone may be incomplete. The aldosterone antagonist spironolactone has been shown t...

Descripción completa

Detalles Bibliográficos
Autor principal: Nadin, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Place in Therapy Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321659/
https://www.ncbi.nlm.nih.gov/pubmed/22500149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321659/
https://www.ncbi.nlm.nih.gov/pubmed/22500149

Ejemplares similares